Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Two additions to the interaction checker

Friday 27 April 2018

Ibrutinib and venetoclax are now listed in the interaction checker as cancer drugs and interactions can be found for all the comedications.

  • Ibrutinib (Imbruvica®) is a Bruton’s tyrosine kinase inhibitor and is indicated for the treatment of mantle cell lymphoma, chronic lymphocytic B-cell leukemia and Waldenström macroglobulinemia.
  • Venetoclax (Venclyxto®, Venclexta®) is a BCL-2 inhibitor and is indicated for the treatment of chronic lymphocytic B-cell leukemia.
ENDORSED BY
Bopa